Targazyme, Inc.

Targazyme, Inc. (formerly America Stem Cell, Inc.) is a clinical-stage biopharmaceutical company developing and commercializing breakthrough products designed to improve outcomes for patients receiving cell therapy. 

Our most advanced product, TZ101, improves the therapeutic potential of cells by enhancing migration to selective sites in the body and improving retention in tissue. This will increase the effectiveness of the cells in numerous disease indications.